Evidence map›Paper›PMID 36369770›Full record

ArticleBirth defects research2022

Prevalence of vascular disruption anomalies and association with young maternal age: A EUROCAT study to compare the United Kingdom with other European countries.

Joan K Morris, Diana Wellesley, Elizabeth Limb, Jorieke E H Bergman, Agnieszka Kinsner-Ovaskainen, Marie Claude Addor, Jennifer M Broughan, Clara Cavero-Carbonell, Carlos M Dias, Luis-Javier Echevarría-González-de-Garibay and 18 more

Open access · hybridAbstract read
In one paragraph

Article in Birth defects research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

28 authors at 20 institutions in 17 countries.

Joan K MorrisSt George's, University of London, London, United Kingdom.ORCID 0000-0002-7164-612X
Diana WellesleyClinical Genetics, University of Southampton and Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, United Kingdom.
Elizabeth LimbSt George's, University of London, London, United Kingdom.
Jorieke E H BergmanUniversity of Groningen, University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands.ORCID 0000-0002-3929-3619
Agnieszka Kinsner-OvaskainenEuropean Commission, Joint Research Centre (JRC), Ispra, Italy.
Marie Claude AddorDepartment of Woman-Mother-Child, University Medical Center CHUV, Lausanne, Switzerland.
Jennifer M BroughanNational Disease Registration Service, NHS Digital, Leeds, United Kingdom.
Clara Cavero-CarbonellRare Diseases Research Unit, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region, Valencia, Spain.
Carlos M DiasDepartment of Epidemiology, Instituto Nacional de Saúde Doutor Ricardo Jorge; Av padre Cruz, Lisbon, Portugal.
Luis-Javier Echevarría-González-de-GaribayMinistry of Health of the Basque Government, Directorate for Healthcare Planning, Organisation and Evaluation, Vitoria-Gasteiz, Spain.
Miriam GattDirectorate for Health Information and Research, Malta Congenital Anomalies Registry, G'Mangia, Malta.
Martin HaeuslerMedical University of Graz, Austria.
Ingeborg BarisicChildren's Hospital Zagreb, Centre of Excellence for Reproductive and Regenerative Medicine, Medical School University of Zagreb, Zagreb, Croatia.
Kari KlungsoyrDepartment of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.
Nathalie LelongUniversité de Paris, INSERM U1153, CRESS, Obstetrical Perinatal and Pediatric Epidemiology Research Team (EPOPé), Paris, France.
Anna Materna-KirylukPolish Registry of Congenital Malformations, Department of Medical Genetics, Poznan University of Medical Sciences, Poznan, Poland.
Amanda NevilleCenter for Clinical and Epidemiological Research, University of Ferrara, Ferrara, Italy.
Vera NelenProvincial Institute for Hygiene, Antwerp, Belgium.
Mary T O'MahonyDepartment of Public Health, Health Service Executive-South, Cork, Ireland.
Isabelle PerthusAuvergne Registry of Congenital Anomalies (CEMC-Auvergne), Department of Clinical Genetics, Centre de Référence des Maladies Rares, University Hospital of Clermont-Ferrand, CNRS-UMR 6602, Institut Pascal, Axe TGI, équipe PEPRADE, Clermont-Ferrand, France.
Anna PieriniUnit of Epidemiology of Rare Diseases and Congenital Anomalies, Institute of Clinical Physiology, National Research Council, Pisa, Italy.
Judith RankinPopulation Health Sciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom.
Anke RissmannMalformation Monitoring Centre Saxony-Anhalt, Medical Faculty Otto-von-Guericke-University Magdeburg, Magdeburg, Germany.ORCID 0000-0002-9437-2790
Florence RougetBrittany Registry of Congenital Anomalies, CHU Rennes, Univ Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, Rennes, France.
Geraldine SayersHealth Intelligence, Research and Development Health Service Executive, Dublin, Ireland.
Sarah StevensNational Disease Registration Service, NHS Digital, Leeds, United Kingdom.
David TuckerPublic Health Knowledge and Research, Public Health Wales, Singleton Hospital, Swansea, United Kingdom.
Ester GarneDepartment of Paediatrics and Adolescent Medicine, Lillebaelt Hospital, University Hospital of Southern Denmark, Kolding, Denmark.ORCID 0000-0003-0430-2594
Health Service Executive · IEInserm · FRNHS Digital · GBSt George's, University of London · GBBasque Government · ESCentre National de la Recherche Scientifique · FRFundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana · ESIstituto di Fisiologia Clinica · ITJoint Research Centre · ITLillebaelt Hospital · DKMedical University of Graz · ATMinistry for Health · MTMother Hospital · INNational Institute of Health Dr. Ricardo Jorge · PTNewcastle University · GBNorwegian Institute of Public Health · NOOtto-von-Guericke-Universität Magdeburg · DEPoznan University of Medical Sciences · PLPrincess Anne Hospital · GBProvincial Institute for Hygiene · BE

Funding

Medical Research Council MR/K02325X/1
6 · The paper itself

Abstract

backgroundYounger mothers are at a greater risk of having a pregnancy with gastroschisis and the risk is higher in the United Kingdom than other European countries. Gastroschisis is thought to be a vascular disruption anomaly and the aim of this study was to analyze the prevalence of other possible vascular disruption anomalies to determine whether both the younger maternal age and the UK associations also occur with these anomalies.

methodsAll pregnancies with anomalies considered potentially due to vascular disruption from January 1, 2005 to December 31, 2017 from 26 European population-based congenital anomaly registries who were members of EUROCAT were analyzed. Multilevel models were used to allow for differences between registries when analyzing associations with maternal age, year of birth and whether the registry was in the United Kingdom.

resultsThere were 5,220 cases with potential vascular disruption anomalies, excluding chromosomal and genetic conditions, with a prevalence of 8.85 per 10,000 births in the United Kingdom and 5.44 in the other European countries. The prevalence per 10,000 births of gastroschisis (4.45 vs. 1.56) and congenital constriction bands (0.83 vs. 0.42) was significantly higher in the United Kingdom, even after adjusting for maternal age. However, transverse limb reduction defects had a similar prevalence (2.16 vs. 2.14 per 10,000). The expected increased prevalence in younger mothers was observed for vascular disruption anomalies overall and for the individual anomalies: gastroschisis and congenital constriction bands.

conclusionVascular disruption anomalies that had an increased risk for younger mothers (such as gastroschisis) had a higher maternal age standardized prevalence in the United Kingdom, while vascular disruption anomalies with weaker associations with younger mothers (such as transverse limb reduction defects) did not have an increased prevalence in the United Kingdom, which may indicate a different etiology for these anomalies.

Indexed as

Cardiovascular AbnormalitiesGastroschisisVascular MalformationsEuropeFemaleHumansMaternal AgePregnancyPrevalenceUnited Kingdomanomaliescongenitaldisruptionsurveillancevascular

Identifiers

PMID36369770
PMCPMC10099853
OpenAlexW4309161825

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.